Tag: BD
Aspirex achieves 78% two-year primary patency rate in P-MAX postmarket observational...
At the Leipzig Interventional Course (LINC) 2024 (May 28–31, Leipzig, Germany), Michael Lichtenberg (Arnsberg Vascular Clinic, Arnsberg, Germany) shared for the first time a...
Nitinol stents placed in iliac veins “not associated with prolonged back...
In a retrospective review of over 600 patients who underwent iliac vein stent placement, the development of back pain was found to be unrelated...
Venous Summit 2023: Holistic, multidisciplinary approach to venous care is “mandatory”
This advertorial, sponsored by BD, is intended only for readers outside the USA.
“A dedicated, holistic venous approach is mandatory—including deep, superficial and pelvic venous...
Venovo venous stent returns to US market after 2021 recall
BD recently announced that its Venovo venous stent is back on the US market following a recall last year.
In 2019, the company reported that...
BD acquires Venclose to extend chronic venous disease treatment portfolio
BD announced today it has acquired Venclose, a provider of solutions for the treatment of chronic venous insufficiency (CVI).
"We are committed to setting a...
Case report: Recanalisation of chronic iliofemoral venous occlusion in a patient...
This advertorial, sponsored by BD, is only available in selected countries and geographies.
In this case report for Venous News, experts outline the importance...
Case report: Recanalisation of chronic iliofemoral venous occlusion in a patient...
This advertorial, sponsored by BD, is only available in selected countries and geographies.
A downloadable version of this advertorial can be found here.
In this...
BD announces launch of Halo One thin-walled guiding sheath
BD has announced the launch of the Halo One thin-walled guiding sheath, designed to perform as both a guiding sheath and an introducer sheath,...
A Deeper Dive into the Venovo™ Venous Stent System
The venous space continues to evolve in the United States, and many physicians are learning how to navigate through the challenges of the venous...
A Deeper Dive into the Venovo™ Venous Stent System
Venous News talks with Gerard O'Sullivan, FSIR, FEBIR, University College Hospital, Galway, Ireland. This article is supported by BD Interventional.
Disclosures: Dr. Gerard O'Sullivan reports...
The new Venovo Venous Stent is changing clinical practice
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly...
One-year results of VERNACULAR trial show significant improvement in patency rate...
Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the...
VERNACULAR trial 12-month data show successful use of Venovo stent in...
The 12-month results from the VERNACULAR trial have shown that the Venovo venous stent (BD Interventional) is successful when deployed in obstructive iliac and...
One-year data from venous stent registry “promising”
Efficacy data from the Arnsberg Registry at 12 months are promising, with high primary patency rates for a dedicated venous stent.
Presenting the data at...